Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Race Oncology Ltd. ( (AU:RAC) ) has shared an update.
Race Oncology Ltd. has released its trading policy, which outlines the guidelines for dealing with securities or derivatives by its key management personnel, employees, and applicable consultants. The policy aims to prevent insider trading by ensuring that these individuals are aware of the legal implications and timing considerations when buying or selling the company’s securities. This announcement underscores the company’s commitment to transparency and regulatory compliance, potentially enhancing its reputation and trust among stakeholders.
More about Race Oncology Ltd.
Race Oncology Ltd. operates in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company is engaged in researching and providing innovative solutions for oncology treatment, aiming to improve patient outcomes in the cancer treatment market.
Average Trading Volume: 234,024
Technical Sentiment Signal: Buy
Current Market Cap: A$535.4M
See more data about RAC stock on TipRanks’ Stock Analysis page.